Cannabis and Hemp Industry Investment News

Cannabis Industry Press Releases and News Articles from the best investment journalist in the industry. Stay updated on all cannabis investment news from every online source, on MjInvest.com
The company said the PLUS line is aimed at offering "competitively-priced products" with some of the “highest amounts of CBD found in the market" The company said its best-selling topical relief Cream and elixirs will launch the PLUS line 1933 Industries Inc () (), a cannabis company with a diverse portfolio of consumer-driven brands, said Wednesda
EuroLife’s goal is to establish a network of health and wellness retail locations focused on healthy lifestyle options, including specialty plant-based foods EuroLife offered nearly 6 million shares at a price of C$0.18 per share for total proceeds of more than C$1 million Inc () (OTCPINK:EURPF) released an investor update after the bell Tuesday, h
ESI will exclusively distribute Innocan’s CBD products in Canada and manufacture them at its facility in Saskatchewan Innocan’s products include its Relief and Go CBD Spray and Cream as well as the SHIR Eye Serum, Face Cream and Night Cream. Innocan Pharma Corporation () announced Tuesday that its subsidiary Innocan Israel signed a manufacturing an
Clarke is co-founder and CEO of consultancy Stratus Designs Ltd, which specializes in the planning, layout, design, commissioning and inspection of cannabis and hemp cultivation and processing facilities Clarke said "optimizing the design of BevCanna's facility is critical in ensuring operational and regulatory excellence" BevCanna Enterprises Inc
The group noted that Mohamed brings over 20 years of private and public sector experience having built an exceptional reputation in business development, capital markets, operational streamlining, mergers, acquisitions, and internal audit He currently serves as chief executive officer and a director of Softlab9 Technologies Inc. () has announced th
What are you searching for? viewFSD Pharma Inc (NASDAQ:HUGE) () CEO Raza Bokhari tells Proactive it has closed US$10 million in a registered direct offering. Bokhari says the offering comes as the Canadian company actively works to submit an Investigational New Drug Application to the FDA to use its FSD201 as a possible treatment to reduce lung inf
What are you searching for? viewAgraFlora Organics International Inc. The firm said it agreed with holders of its 10% senior unsecured convertible debentures due March 12, 2021, that provides for the purchase of $3 million aggregate principal amount of the debentures AgraFlora grows, distributes and markets premium cannabis and cannabis-infused pro
The company said its products have “successfully" passed safety assessment in accordance with European Union cosmetic regulation No 1223/2009 CEO Iris Bincovich said compliance with EU regulation is "a major milestone" for the company, after receiving technical validation from the FDA to market its Relief & Go Pain Relief spray in the US Innoca
What are you searching for? viewCannabis One Holdings Inc. Cannabis One (CSE: CBIS) President and Interim CEO Joshua Mann joined Steve Darling from Proactive Vancouver with news the company has changed up their board of directors. Mr Alnoor Nathoo has joined the board and Mann talks about the experience he brings. Mann also discusses his role chang
Five Star’s Double Shot line is a fast-acting beverage that contains 20 milligrams of THC in a variety of flavors and its cannabis-infused tincture beverage enhancers allow users to mix and match flavours AMA will manufacture Five Star products, including its exclusive flavored Double Shot line and flavored cannabis tinctures (photo courtesy of Fiv
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Corp (NASDAQ:IEC) posted strong fiscal third-quarter results on Wednesday that saw its revenue jump 17% year-over-year driven by its ability to deliver “reliable” electronic manufacturing solutions for complex products even during the coronavirus pandemic.
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Inc () (OTC:RCCTF) told investors Wednesday that the company is finalizing agreements and aligning resources to initiate a Phase 3 clinical trial of its drug Bucillamine as a treatment for the coronavirus (COVID-19) in September. The company received appro